Literature DB >> 29865057

Religious Orders Study and Rush Memory and Aging Project.

David A Bennett1,2, Aron S Buchman1,2, Patricia A Boyle1,3, Lisa L Barnes1,2,3, Robert S Wilson1,2,3, Julie A Schneider1,2,4.   

Abstract

BACKGROUND: The Religious Orders Study and Rush Memory and Aging Project are both ongoing longitudinal clinical-pathologic cohort studies of aging and Alzheimer's disease (AD).
OBJECTIVES: To summarize progress over the past five years and its implications for understanding neurodegenerative diseases.
METHODS: Participants in both studies are older adults who enroll without dementia and agree to detailed longitudinal clinical evaluations and organ donation. The last review summarized findings through the end of 2011. Here we summarize progress and study findings over the past five years and discuss new directions for how these studies can inform on aging and AD in the future.
RESULTS: We summarize 1) findings on the relation of neurobiology to clinical AD; 2) neurobiologic pathways linking risk factors to clinical AD; 3) non-cognitive AD phenotypes including motor function and decision making; 4) the development of a novel drug discovery platform.
CONCLUSION: Complexity at multiple levels needs to be understood and overcome to develop effective treatments and preventions for cognitive decline and AD dementia.

Entities:  

Keywords:  Alzheimer’s disease; cognitive decline; decision making; dementia; drug zzm321990discovery; epidemiology; motor function; neuropathology; omics

Mesh:

Year:  2018        PMID: 29865057      PMCID: PMC6380522          DOI: 10.3233/JAD-179939

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  440 in total

1.  Assessment of lifetime participation in cognitively stimulating activities.

Authors:  Robert Wilson; Lisa Barnes; David Bennett
Journal:  J Clin Exp Neuropsychol       Date:  2003-08       Impact factor: 2.475

2.  Metric properties of nurses' ratings of parkinsonian signs with a modified Unified Parkinson's Disease Rating Scale.

Authors:  D A Bennett; K M Shannon; L A Beckett; C G Goetz; R S Wilson
Journal:  Neurology       Date:  1997-12       Impact factor: 9.910

Review 3.  Epigenomics of Alzheimer's disease.

Authors:  David A Bennett; Lei Yu; Jingyun Yang; Gyan P Srivastava; Cristin Aubin; Philip L De Jager
Journal:  Transl Res       Date:  2014-05-16       Impact factor: 7.012

4.  Common variants in DRD2 are associated with sleep duration: the CARe consortium.

Authors:  Brian E Cade; Daniel J Gottlieb; Diane S Lauderdale; David A Bennett; Aron S Buchman; Sarah G Buxbaum; Philip L De Jager; Daniel S Evans; Tibor Fülöp; Sina A Gharib; W Craig Johnson; Hyun Kim; Emma K Larkin; Seung Ku Lee; Andrew S Lim; Naresh M Punjabi; Chol Shin; Katie L Stone; Gregory J Tranah; Jia Weng; Kristine Yaffe; Phyllis C Zee; Sanjay R Patel; Xiaofeng Zhu; Susan Redline; Richa Saxena
Journal:  Hum Mol Genet       Date:  2015-10-13       Impact factor: 6.150

5.  The influence of cognitive decline on well-being in old age.

Authors:  Robert S Wilson; Patricia A Boyle; Eisuke Segawa; Lei Yu; Christopher T Begeny; Sophia E Anagnos; David A Bennett
Journal:  Psychol Aging       Date:  2013-02-18

6.  Cytomegalovirus infection and risk of Alzheimer disease in older black and white individuals.

Authors:  Lisa L Barnes; Ana W Capuano; Alison E Aiello; Arlener D Turner; Robert H Yolken; E Fuller Torrey; David A Bennett
Journal:  J Infect Dis       Date:  2014-08-08       Impact factor: 5.226

7.  Contribution of Alzheimer disease to mortality in the United States.

Authors:  Bryan D James; Sue E Leurgans; Liesi E Hebert; Paul A Scherr; Kristine Yaffe; David A Bennett
Journal:  Neurology       Date:  2014-03-05       Impact factor: 9.910

8.  Silent cerebral infarction in a community-based autopsy series in Japan. The Hisayama Study.

Authors:  A Shinkawa; K Ueda; Y Kiyohara; I Kato; K Sueishi; M Tsuneyoshi; M Fujishima
Journal:  Stroke       Date:  1995-03       Impact factor: 7.914

9.  FASTKD2 is associated with memory and hippocampal structure in older adults.

Authors:  V K Ramanan; K Nho; L Shen; S L Risacher; S Kim; B C McDonald; M R Farlow; T M Foroud; S Gao; H Soininen; I Kłoszewska; P Mecocci; M Tsolaki; B Vellas; S Lovestone; P S Aisen; R C Petersen; C R Jack; L M Shaw; J Q Trojanowski; M W Weiner; R C Green; A W Toga; P L De Jager; L Yu; D A Bennett; A J Saykin
Journal:  Mol Psychiatry       Date:  2014-11-11       Impact factor: 15.992

10.  Association of white matter hyperintensities and gray matter volume with cognition in older individuals without cognitive impairment.

Authors:  Zoe Arvanitakis; Debra A Fleischman; Konstantinos Arfanakis; Sue E Leurgans; Lisa L Barnes; David A Bennett
Journal:  Brain Struct Funct       Date:  2015-04-02       Impact factor: 3.270

View more
  260 in total

1.  Brain Insulin Signaling, Alzheimer Disease Pathology, and Cognitive Function.

Authors:  Zoe Arvanitakis; Hoau-Yan Wang; Ana W Capuano; Amber Khan; Bouchra Taïb; Frederick Anokye-Danso; Julie A Schneider; David A Bennett; Rexford S Ahima; Steven E Arnold
Journal:  Ann Neurol       Date:  2020-07-27       Impact factor: 10.422

2.  Genetics of Gene Expression in the Aging Human Brain Reveal TDP-43 Proteinopathy Pathophysiology.

Authors:  Hyun-Sik Yang; Charles C White; Hans-Ulrich Klein; Lei Yu; Christopher Gaiteri; Yiyi Ma; Daniel Felsky; Sara Mostafavi; Vladislav A Petyuk; Reisa A Sperling; Nilüfer Ertekin-Taner; Julie A Schneider; David A Bennett; Philip L De Jager
Journal:  Neuron       Date:  2020-06-10       Impact factor: 17.173

3.  Human Hippocampal Neurogenesis Persists in Aged Adults and Alzheimer's Disease Patients.

Authors:  Matthew K Tobin; Kianna Musaraca; Ahmed Disouky; Aashutosh Shetti; Abdullah Bheri; William G Honer; Namhee Kim; Robert J Dawe; David A Bennett; Konstantinos Arfanakis; Orly Lazarov
Journal:  Cell Stem Cell       Date:  2019-05-23       Impact factor: 24.633

4.  Subtypes Based on Neuropsychological Performance Predict Incident Dementia: Findings from the Rush Memory and Aging Project.

Authors:  Andrea R Zammit; Graciela Muniz-Terrera; Mindy J Katz; Charles B Hall; Ali Ezzati; David A Bennett; Richard B Lipton
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

5.  Neuropsychological latent classes at enrollment and postmortem neuropathology.

Authors:  Andrea R Zammit; Charles B Hall; David A Bennett; Ali Ezzati; Mindy J Katz; Graciela Muniz-Terrera; Richard B Lipton
Journal:  Alzheimers Dement       Date:  2019-08-13       Impact factor: 21.566

6.  Blood and brain gene expression trajectories mirror neuropathology and clinical deterioration in neurodegeneration.

Authors:  Yasser Iturria-Medina; Ahmed F Khan; Quadri Adewale; Amir H Shirazi
Journal:  Brain       Date:  2020-02-01       Impact factor: 13.501

7.  TIGAR: An Improved Bayesian Tool for Transcriptomic Data Imputation Enhances Gene Mapping of Complex Traits.

Authors:  Sini Nagpal; Xiaoran Meng; Michael P Epstein; Lam C Tsoi; Matthew Patrick; Greg Gibson; Philip L De Jager; David A Bennett; Aliza P Wingo; Thomas S Wingo; Jingjing Yang
Journal:  Am J Hum Genet       Date:  2019-06-20       Impact factor: 11.025

8.  Motoric cognitive risk syndrome and predictors of transition to dementia: A multicenter study.

Authors:  Joe Verghese; Cuiling Wang; David A Bennett; Richard B Lipton; Mindy J Katz; Emmeline Ayers
Journal:  Alzheimers Dement       Date:  2019-06-01       Impact factor: 21.566

9.  Using Transcriptomic Hidden Variables to Infer Context-Specific Genotype Effects in the Brain.

Authors:  Bernard Ng; William Casazza; Ellis Patrick; Shinya Tasaki; Gherman Novakovsky; Daniel Felsky; Yiyi Ma; David A Bennett; Chris Gaiteri; Philip L De Jager; Sara Mostafavi
Journal:  Am J Hum Genet       Date:  2019-08-22       Impact factor: 11.025

10.  Large-scale proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation.

Authors:  Erik C B Johnson; Eric B Dammer; Duc M Duong; Lingyan Ping; Maotian Zhou; Luming Yin; Lenora A Higginbotham; Andrew Guajardo; Bartholomew White; Juan C Troncoso; Madhav Thambisetty; Thomas J Montine; Edward B Lee; John Q Trojanowski; Thomas G Beach; Eric M Reiman; Vahram Haroutunian; Minghui Wang; Eric Schadt; Bin Zhang; Dennis W Dickson; Nilüfer Ertekin-Taner; Todd E Golde; Vladislav A Petyuk; Philip L De Jager; David A Bennett; Thomas S Wingo; Srikant Rangaraju; Ihab Hajjar; Joshua M Shulman; James J Lah; Allan I Levey; Nicholas T Seyfried
Journal:  Nat Med       Date:  2020-04-13       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.